Melanoma patients classified with a low-risk score based on the ITRGM signature exhibit extensive infiltration of immune cells, notably CD4+ T cells, M1-polarized macrophages, CD8+ T cells, NK cells, and B cells. The gene discussed is CD4; the disease is melanoma.